Literature DB >> 28839693

The future developments in hepatology: no need for a jaundiced view.

Ahmed Mohamed Elsharkawy1,2, Mark Hudson3.   

Abstract

There have been major advances in the diagnosis and management of all forms of liver disease since the British Society of Gastroenterology first came into existence 75 years ago. In this review some of the exciting developments that are likely to enter into routine clinical practice over the next 5 years are highlighted. It is suggested that some critical changes need to take place in UK hepatology over the next decade to ensure that the management of liver disease in this country continues to be among the best in the world.

Entities:  

Year:  2012        PMID: 28839693      PMCID: PMC5551950          DOI: 10.1136/flgastro-2012-100153

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  41 in total

Review 1.  Treatment of non-genotype 1 hepatitis C virus patients.

Authors:  Alessandra Mangia; Leonardo Mottola
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 2.  Generic immunosuppression in solid organ transplantation: a Canadian perspective.

Authors:  Jennifer J Harrison; Jeffrey R Schiff; Christian J Coursol; Christopher J A Daley; Anne I Dipchand; Norine M Heywood; Tammy M Keough-Ryan; Paul A Keown; Gary A Levy; Dale C Lien; Jenny R Wichart; Marcelo Cantarovich
Journal:  Transplantation       Date:  2012-04-15       Impact factor: 4.939

3.  The potential impact of an opt-out system for organ donation in the UK.

Authors:  Romelie Rieu
Journal:  J Med Ethics       Date:  2010-09       Impact factor: 2.903

Review 4.  Management of critically-ill cirrhotic patients.

Authors:  Pere Ginès; Javier Fernández; François Durand; Faouzi Saliba
Journal:  J Hepatol       Date:  2012       Impact factor: 25.083

5.  High-resolution characterization of a hepatocellular carcinoma genome.

Authors:  Yasushi Totoki; Kenji Tatsuno; Shogo Yamamoto; Yasuhito Arai; Fumie Hosoda; Shumpei Ishikawa; Shuichi Tsutsumi; Kohtaro Sonoda; Hirohiko Totsuka; Takuya Shirakihara; Hiromi Sakamoto; Linghua Wang; Hidenori Ojima; Kazuaki Shimada; Tomoo Kosuge; Takuji Okusaka; Kazuto Kato; Jun Kusuda; Teruhiko Yoshida; Hiroyuki Aburatani; Tatsuhiro Shibata
Journal:  Nat Genet       Date:  2011-04-17       Impact factor: 38.330

6.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

Review 7.  Management of varices in cirrhosis.

Authors:  Ulrich Thalheimer; Christos Triantos; John Goulis; Andrew K Burroughs
Journal:  Expert Opin Pharmacother       Date:  2011-01-27       Impact factor: 3.889

8.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

Authors:  Eugenia E Calle; Carmen Rodriguez; Kimberly Walker-Thurmond; Michael J Thun
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

Review 9.  Interferon free hepatitis C treatment regimens: the beginning of another era.

Authors:  Fred Poordad; Grace M Chee
Journal:  Curr Gastroenterol Rep       Date:  2012-02

10.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.